SGLT2 Inhibitor Treatment Outcome in Nonalcoholic Fatty Liver Disease Complicated with Diabetes Mellitus: The Long-term Effects on Clinical Features and Liver Histopathology

OBJECTIVE: The aim of this study was to determine the long-term effects of a sodium-glucose cotransporter 2 inhibitor (SGLT2i) in nonalcoholic fatty liver disease (NAFLD) patients with type 2 diabetes mellitus (T2DM) on the clinical features and liver histopathology. METHODS: In this retrospective s...

Descripción completa

Detalles Bibliográficos
Autores principales: Akuta, Norio, Kawamura, Yusuke, Fujiyama, Shunichiro, Sezaki, Hitomi, Hosaka, Tetsuya, Kobayashi, Masahiro, Kobayashi, Mariko, Saitoh, Satoshi, Suzuki, Fumitaka, Suzuki, Yoshiyuki, Arase, Yasuji, Ikeda, Kenji, Kumada, Hiromitsu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7492114/
https://www.ncbi.nlm.nih.gov/pubmed/32448832
http://dx.doi.org/10.2169/internalmedicine.4398-19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7492114/
https://www.ncbi.nlm.nih.gov/pubmed/32448832
http://dx.doi.org/10.2169/internalmedicine.4398-19

Ejemplares similares